Triple

T10291904
Position Surface form Disambiguated ID Type / Status
Subject andexanet alfa E241384 entity
Predicate hasTradeName P24555 FINISHED
Object Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
E852344 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Andexxa | Statement: [andexanet alfa, hasTradeName, Andexxa]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Andexxa
Context triple: [andexanet alfa, hasTradeName, Andexxa]
  • A. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • B. Acurenam
    Acurenam is a town located in the Centro Sur province of Equatorial Guinea.
  • C. Auscitain
    An Auscitain is a resident or native of Auch, a historic town in the Occitanie region of southwestern France.
  • D. Plaxtol
    Plaxtol is a small rural village and civil parish in Kent, England, known for its historic buildings and surrounding countryside.
  • E. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Andexxa
Triple: [andexanet alfa, hasTradeName, Andexxa]
Generated description
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Andexxa
Target entity description: Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
  • A. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • B. Acurenam
    Acurenam is a town located in the Centro Sur province of Equatorial Guinea.
  • C. Auscitain
    An Auscitain is a resident or native of Auch, a historic town in the Occitanie region of southwestern France.
  • D. Plaxtol
    Plaxtol is a small rural village and civil parish in Kent, England, known for its historic buildings and surrounding countryside.
  • E. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381aaafc08190af475ef58dc16aba completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4d2d35f048190a215493acdf1f718 completed April 7, 2026, 9:48 a.m.
NED1 Entity disambiguation (via context triple) batch_69d6f85dcbac8190a2ac66354010e328 completed April 9, 2026, 12:52 a.m.
NEDg Description generation batch_69d6fcaee26c8190a19f7d07a63531f6 completed April 9, 2026, 1:11 a.m.
NED2 Entity disambiguation (via description) batch_69d6fd879ab88190b0a47295f5d7ad4d completed April 9, 2026, 1:14 a.m.
Created at: April 6, 2026, 11:42 a.m.